Prevalence of Post-COVID-19 Condition in Adults 8.4 Percent in 2023
THURSDAY, Dec. 26, 2024 -- The prevalence of post-COVID-19 condition (PCC) was 8.4 percent among U.S. adults in 2023, according to a research letter published online Dec. 13 in JAMA Network Open.
Anjel Vahratian, Ph.D., from the U.S. Centers for Disease Control and Prevention in Hyattsville, Maryland, and colleagues described the prevalence of PCC (ever and current) and self-reported limitations of activity due to symptoms of PCC using data from the 2023 National Health Interview Survey adult interview.
Among 29,522 respondents in 2023, 8.4, 3.6, and 2.3 percent reported that they had ever had PCC, currently had PCC, and currently had activity-limiting PCC, respectively. The researchers found that across all three outcomes, there were significant differences by sex, sexual orientation, age, race and Hispanic origin, family income, and urbanization. With increasing family income, there was a decrease in the percentage of adults who ever had PCC, currently had PCC, and currently had activity-limiting PCC. With increasing rurality of place of residence, the prevalence of these three outcomes increased. Overall, 64.5 percent of adults who currently had PCC experienced symptoms that were activity-limiting.
"This work supports the Department of Health and Human Services efforts to assess the overall disease burden of PCC across the U.S. population," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Further Support and Information on COVID-19
Read this next
Features of Immunesenescence Present in Early Stages of Rheumatoid Arthritis
THURSDAY, Sept. 11, 2025 -- Some features of immunesenescence are present in the very early stages of rheumatoid arthritis (RA), according to a study published online Sept. 3 in...
Urine Biomarker Panel Sensitive, Specific for Prostate Cancer Diagnosis
THURSDAY, Sept. 11, 2025 -- A urine-based biomarker panel has high accuracy for diagnosing prostate cancer (PCa), according to a study published in the September issue of...
Hospitals Vary in Their Definition of Blood Culture Contamination
THURSDAY, Sept. 11, 2025 -- U.S. hospitals vary in how they define blood culture contamination (BCC), according to a study published online July 11 in the Journal of Clinical...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.